We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current BIMI market cap is 4.33M. The company's latest EPS is USD -1.6040 and P/E is -0.19.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.32M | -5.43M | 3.2M | 5.56M | 2.52M |
| Operating Income | -3.09M | -7.41M | 581k | 1.37M | -3.15M |
| Net Income | -3.71M | -11.8M | -884k | 2.73M | -3.13M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.54M | 158k | 12.85M | 27.08M | 11.83M |
| Operating Income | -15.79M | -1.71M | -3.81M | -34.24M | -15.34M |
| Net Income | -16.79M | -4.44M | -2M | -34.99M | -22.39M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 33M | 35.71M | 36.27M | 36.66M | 35.04M |
| Total Liabilities | 22.79M | 30.5M | 27.65M | 24.15M | 24.9M |
| Total Equity | 10.21M | 5.22M | 8.62M | 12.51M | 10.14M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23.05M | 30.06M | 33.2M | 38.13M | 35.71M |
| Total Liabilities | 13.07M | 21.55M | 16.31M | 26.79M | 30.5M |
| Total Equity | 9.99M | 8.51M | 16.89M | 11.34M | 5.22M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.33M | -10.26M | 2.82M | 2.25M | 764k |
| Investing | -180k | -538k | N/A | N/A | -604k |
| Financing | 4.36M | 8.43M | -2.17M | -1.84M | -804k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -345k | -2.07M | -3.52M | -1.28M | -10.26M |
| Investing | N/A | 167k | -725k | -697k | -538k |
| Financing | 212k | 1.84M | 3.99M | 6.14M | 8.43M |
| Market Cap | 4.33M |
| Price to Earnings Ratio | -0.19 |
| Price to Sales Ratio | 0.37 |
| Price to Cash Ratio | 1.85 |
| Price to Book Ratio | 0.83 |
| Dividend Yield | - |
| Shares Outstanding | 13.96M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | BIMI International Medical Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.usbimi.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
